Ampio Pharm Stock Current Asset
| AMPEDelisted Stock | USD 0.24 0.01 4.35% |
Ampio Pharm fundamentals help investors to digest information that contributes to Ampio Pharm's financial success or failures. It also enables traders to predict the movement of Ampio Pink Sheet. The fundamental analysis module provides a way to measure Ampio Pharm's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ampio Pharm pink sheet.
Ampio |
Ampio Pharm Company Current Asset Analysis
Ampio Pharm's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Ampio Pharm Current Asset | 29.23 M |
Most of Ampio Pharm's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ampio Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Ampio Pharm has a Current Asset of 29.23 M. This is 98.64% lower than that of the Pharmaceuticals sector and 97.24% lower than that of the Health Care industry. The current asset for all United States stocks is 99.69% higher than that of the company.
Ampio Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ampio Pharm's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics of similar companies.Ampio Pharm is currently under evaluation in current asset category among its peers.
Ampio Fundamentals
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.62 | ||||
| Current Valuation | (3.33 M) | ||||
| Shares Outstanding | 1.14 M | ||||
| Shares Owned By Insiders | 1.56 % | ||||
| Shares Owned By Institutions | 4.19 % | ||||
| Number Of Shares Shorted | 32.9 K | ||||
| Price To Earning | 28.57 X | ||||
| Price To Book | 0.21 X | ||||
| EBITDA | (8.63 M) | ||||
| Net Income | (8.63 M) | ||||
| Cash And Equivalents | 23.25 M | ||||
| Cash Per Share | 0.10 X | ||||
| Total Debt | 274 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 4.85 X | ||||
| Book Value Per Share | 4.03 X | ||||
| Cash Flow From Operations | (8.56 M) | ||||
| Short Ratio | 0.31 X | ||||
| Earnings Per Share | (10.66) X | ||||
| Target Price | 2.0 | ||||
| Beta | 1.95 | ||||
| Market Capitalization | 340.61 K | ||||
| Total Asset | 5.74 M | ||||
| Retained Earnings | (242.53 M) | ||||
| Working Capital | 3.36 M | ||||
| Current Asset | 29.23 M | ||||
| Current Liabilities | 5.52 M | ||||
| Net Asset | 5.74 M |
About Ampio Pharm Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |